Rituximab with high-dose methotrexate in primary central nervous system lymphoma
Author:
Affiliation:
1. Centre for Lymphoid Cancer and Department of Medical Oncology; British Columbia Cancer Agency; Vancouver British Columbia Canada
2. Leukemia/Bone Marrow Transplantation Program of BC; Vancouver British Columbia Canada
Publisher
Wiley
Subject
Hematology
Reference29 articles.
1. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009;Dolecek;Neuro Oncol,2012
2. Pathology and genetics of primary central nervous system and intraocular lymphoma;Rubenstein;Hematol Oncol Clin North Am,2005
3. How I treat CNS lymphomas;Rubenstein;Blood,2013
4. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315;Nelson;Int J Radiat Oncol Biol Phys,1992
5. Treatment for primary CNS lymphoma: The next step;Abrey;J Clin Oncol,2000
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2023-10
2. Primary Central Nervous System Lymphoma Presenting as Isolated Multiple Cranial Neuropathies: An Extremely Rare Case;Cureus;2023-07-08
3. Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma;Scientific Reports;2022-12-13
4. First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients;Annals of Hematology;2022-01-04
5. The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma;Cancers;2021-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3